Noah Berkowitz

Dr. Noah Berkowitz is a Chief Medical Officer at Iovance Biotherapeutics, Inc. and a President & Chief Executive Officer at HaptoGuard, Inc. Dr. Berkowitz was previously employed as a Chief Medical Officer by Arvinas, Inc., a President, CEO, Secretary & Director by Synvista Therapeutics, Inc., a Senior Vice President & Head-Hematology by Bristol Myers Squibb Co., a Vice President-Clinical Development by IMPATH, Inc., a Founder by Physician's Choice, Inc., a Consultant by Predix Pharmaceuticals, Inc., and a Consultant by Teva Pharmaceuticals USA, Inc. He also served on the board at Poseida Therapeutics, Inc. He received his undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from The Trustees of Columbia University in The City of New York.